← Open Payments lookup

LISA MORRIS: Open Payments

NPI 1730710344 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$316 in 16 payments from 11 companies in 2025. Trend: 2023 $122 · 2024 $119 · 2025 $316

Food & beverage: $316
CompanyPaymentsAmount
Exeltis, USA Inc.3$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$45
ABBVIE INC.2$36
Amgen Inc.2$31
Organogenesis Inc.1$28
Lilly USA, LLC1$25
GlaxoSmithKline, LLC.1$20
Boston Scientific Corporation1$19
Novo Nordisk Inc1$19
Organon LLC1$19

Products named: SLYND, XIFAXAN, OTEZLA, PURAPLY WOUND MATRIX, ZEPBOUND, VRAYLAR, BEXSERO, Bulkamid.

Industry payments across NY — which companies pay providers there.